Entegris, Inc. Q3 FY2025 earnings call

Management Statement and Operational Highlights:

• Dave Reeder, new CEO, emphasized customer intimacy as a top priority, aiming to support customers' technology road maps with deep application expertise, organic innovation, and accelerated product development. He also highlighted accelerating the qualification and ramp of new facilities in Taiwan and Colorado, with the Taiwan facility expected to increase volume in 2026 and the Colorado facility to complete customer product qualifications next year. Additionally, the focus is on improving free cash flow, with record operating cash flow in Q3 and plans to reduce leverage. Linda LaGorga discussed Q3 financials, noting flat year-over-year sales, lower gross margin due to underutilized facilities, and outlined Q4 outlook with sales range, margin expectations, and EPS guidance.

Segment Performance:

• Materials Solutions: Q3 sales were $349 million, up 1% year-on-year and down 2% sequentially. The modest growth year-on-year was driven primarily by CMP consumables and cleaning chemistries, while the sequential decline was due to demand shifts from the evolving trade environment. Adjusted operating margin for MS was 18.9% for the quarter, down year-over-year and sequentially, driven by lower production volumes and product mix.
• Advanced Purity Solutions: Q3 sales were $461 million, essentially flat year-on-year and up 5% sequentially. The sequential increase was driven by the strength of the liquid filtration business, which had a record quarter in Q3. Adjusted operating margin for APS was 25.9% for the quarter, with the year-on-year decline in margin due to underutilization of manufacturing facilities and incremental fixed costs as new facilities were ramped, and the sequential increase due to sales leverage.

Guidance:

• Q4 sales expected to range from $790 million to $830 million. Gross margin of 43% to 44% (GAAP and non-GAAP). GAAP operating expenses $232 million to $236 million and non-GAAP operating expenses $184 million to $188 million. EBITDA margin range 26.5% to 27.5%. Net interest expense approximately $47 million. Non-GAAP tax rate expected to return to ~15% in Q4. GAAP EPS $0.35 to $0.42 per share and non-GAAP EPS $0.62 to $0.69 per share. Full-year free cash flow margin expected in the low double digits. CapEx expected to materially decrease year-over-year as the significant manufacturing investment cycle from 2022 is largely worked through.

Risks:

• Industry slowdown impacting CapEx-driven revenue, as seen in the decline of FOUP and fluid handling revenue in APS.
• Manufacturing facility underutilization affecting gross margin, despite having strategic manufacturing assets.
• Geopolitical trade issues, such as BIS bands, potentially impacting sales to certain regions, though currently not materially affecting Q3 and expected to have limited impact in 2026.

Q: Jim Schneider with Goldman Sachs asked about strategic and commercial differences and operational improvements Dave Reeder hopes to implement.

A: Dave Reeder mentioned broadening customer engagement to upstream ecosystem partners and mainstream logic customers, and ramping new facilities like Taiwan and Colorado, focusing on qualification and volume increase.

Q: Tim Arcuri with UBS asked about BIS bands impact and utilization across sites.

A: Dave Reeder said BIS bands didn't impact Q3 and not expected to impact 2026. Discussed balancing inventory build, utilization, and free cash flow, with plans to expand profitability and utilization in 2026 with limited incremental CapEx.

Q: Melissa Weathers with Deutsche Bank asked about December quarter guidance and gate-all-around/2-nanometer growth.

A: Dave Reeder said Q4 guidance reflects preparedness for various scenarios, with advanced logic and memory showing optimism, but mainstream having muted recovery. Discussed node transitions and content growth opportunities but noted advanced nodes still represent a small portion of total wafers.

Q: John Roberts with Mizuho asked about demand shift in Materials Solutions and product rationalization for China.

A: Linda LaGorga discussed demand shift in Q2-Q3, and Dave Reeder said over 80% local-for-local manufacturing for China by end of 2025, expecting over 90% in 2026, with minimal impact on revenue.

Q: Elizabeth Sun with Citi asked about 2-nanometer content growth and KSP/Colorado fabs impact on margin.

A: Dave Reeder discussed node transitions and content growth opportunities, and Linda LaGorga said new facilities have strategic value but underutilized now, expecting margin improvement as volume ramps.

Q: Bhavesh Lodaya with BMO Capital Markets asked about capacity utilization and capital allocation after leverage reduction.

A: Dave Reeder said depends on industry growth rate, with strategic assets and ample capacity to capture demand in up cycle. Near-term focus is reducing leverage, with long-term capital allocation to customer focus, operational efficiency, and cash flow generation.

Q: Christopher Parkinson with Wolfe Research asked about APS trends and investor feedback.

A: Dave Reeder discussed APS trends, with liquid filtration strong but fluid management impacted by CapEx slowdown. Investor feedback focused on growth, profitability, and leverage, with plans to expand customer engagement and innovation to address these.

Q: Aleksey Yefremov with KeyBanc Capital Markets asked about KSP site qualification and margin impact.

A: Dave Reeder said behind schedule in KSP qualification but focusing on ramping volume in 2026, with Linda LaGorga noting new facilities have marginal benefit to margin as volume increases.

Q: Edward Yang with Oppenheimer asked about AI exposure, CMP in HBM, and Analyst Day growth formula.

A: Dave Reeder said AI represents 5% of total wafer starts, CMP has wins in HBM but small base. Stated growth formula still holds, expecting outperformance within industry growth expectations.